Analyzing CARA, INSY, and GWPH’s Earnings Trends

CARA, INSY, and GWPH: Comparing Medical Cannabis Stocks(Continued from Prior Part)Earnings trends GW Pharmaceuticals’ (GWPH) net income was -$295.2 million in fiscal 2018—compared to -$170.5 million in fiscal 2017. In the first nine months of